Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 061653
Company: BRISTOL
Company: BRISTOL
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TETREX | TETRACYCLINE PHOSPHATE COMPLEX | EQ 100MG HYDROCHLORIDE | CAPSULE;ORAL | Discontinued | None | No | No |
| TETREX | TETRACYCLINE PHOSPHATE COMPLEX | EQ 250MG HYDROCHLORIDE | CAPSULE;ORAL | Discontinued | None | No | No |
| TETREX | TETRACYCLINE PHOSPHATE COMPLEX | EQ 500MG HYDROCHLORIDE | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/20/1972 | ORIG-1 | Approval |
Label is not available on this site. |